Peter Marocco left his role as Director of the Office of Foreign Assistance, a position in which he oversaw severe cutbacks and layoffs to the agency known as USAID, the State Department said.

Peter Marocco, an official who oversaw the dismantling of the U.S. Agency for International Development (USAID), has exited the State Department, according to the Trump administration.

The President Trump-appointed official who oversaw the dismantling of USAID has abruptly left his role after less than three months in the job, a senior US official has said. Pete Marocco had been ...

President Donald Trump's administration has moved to fire nearly all USAID staff, as billionaire Elon Musk’s Department of Government Efficiency has slashed funding and dismissed contractors ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

Keterangan gambar, Kasus Covid-19 di Indonesia kembali meningkat sejak akhir Oktober lalu akibat kemunculan subvarian baru dari Omicron, seperti EG.2 dan EG.5. 7 Desember 2023 Kasus Covid-19 di ...

A senior State Department official who masterminded the dismantling of the U.S. Agency for International Development (USAID) has left his role after less than three months, a U.S. official said.

Trump administration has moved to fire nearly all USAID staff Marocco may have been pushed out of role Cuts have thrown humanitarian efforts into turmoil April 13 (Reuters) - Pete Marocco ...

President Donald Trump's administration has moved to fire nearly all USAID staff, as billionaire Elon Musk’s Department of Government Efficiency has slashed funding and dismissed contractors across ...

NEW YORK — This “yo-yo” of a year continues for America's nutritional peanut paste manufacturers, nonprofits that have found their lifesaving food packets disrupted by the U.S. State ...

The future of USAID – the world's largest donor of humanitarian aid, including projects to raise the quality and safety of medicines in low- and middle-income countries – is in doubt.